TrialResults-center.org
Search
Menu
Home
Search
Recent trials
Browse pathology
Browse treatment
About us
systematic review
meta-analysis
network meta-analysis
Select
atrial fibrillation
post myocardial infarction
antiarryhtmic
Class III
vs placebo or control
pdf
Filter
hide ongoing
show ongoing
hide ongoing
all ROB
Show all trials
Show only trial at low risk of bias
Hide exploratory trials
all results
Show all trials
Show only trial with conclusive result
Group by
Group by...
nothing
pathology
treatment
patient
comparator
classe
classe comparator
mechanism
clinical condition
MA
in first
nothing
pathology
treatment
patient
comparator
classe
classe comparator
mechanism
clinical condition
in second
nothing
pathology
treatment
patient
comparator
classe
classe comparator
mechanism
clinical condition
in third
Description
Synopsis
Comparison
Treatments
Patients
Characteristics
Method
Risk of bias
References
None
Tools
Indexation
Results
Global trial result
Main results
All results
All result tag
NCT results
All cause death (2)
Adverse events leading to treatment discontinuation (1)
Pro-arrhythmia (1)
Atrial fibrillation recurrence (1)
Cardiovascular death (1)
non cardiovascular death (1)
Cardiac nonarrhythmic death (1)
Cardiac arrhythmic death (1)
Vascular noncardiac death (1)
hospitalization for AF (1)
cardiovascular events (1)
death or hospitalization for cardiac causes (1)
stroke (fatal and non fatal) (1)
myocardial infarction (fatal and non fatal) (1)
hospitalisation for heart failure (1)
Coronary death (1)
Options
Numeric
bar chart
forest plot
medians
Trial
Studied trt
Control trt
patients
tags
ROB
Trial result
All cause death
Adverse events leading to treatment discontinuation
atrial fibrillation
ASAP, 2003
Azimilide
placebo
Low risk of bias
negative
23%
130%
post myocardial infarction
ALIVE, 2004
azimilide
placebo
Low risk of bias
-
×
Modal title